Singular Genomics Systems Inc (OMIC)
15.49
-0.02
(-0.13%)
USD |
NASDAQ |
Sep 27, 16:00
15.60
+0.11
(+0.71%)
After-Hours: 20:00
Singular Genomics Systems SG&A Expense (TTM): 53.22M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 53.22M |
| March 31, 2024 | 56.21M |
| December 31, 2023 | 54.48M |
| September 30, 2023 | 53.09M |
| June 30, 2023 | 51.80M |
| March 31, 2023 | 49.09M |
| December 31, 2022 | 47.26M |
| September 30, 2022 | 45.74M |
| Date | Value |
|---|---|
| June 30, 2022 | 42.33M |
| March 31, 2022 | 36.34M |
| December 31, 2021 | 28.62M |
| September 30, 2021 | 20.18M |
| June 30, 2021 | 13.32M |
| March 31, 2021 | 8.564M |
| December 31, 2020 | 6.287M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
6.287M
Minimum
Dec 2020
56.21M
Maximum
Mar 2024
37.77M
Average
45.74M
Median
Sep 2022
SG&A Expense (TTM) Benchmarks
| Bruker Corp | 805.40M |
| Azenta Inc | 305.65M |
| Harvard Bioscience Inc | 45.99M |
| Bionano Genomics Inc | 71.68M |
| Akoya Biosciences Inc | 76.87M |